MOLINA HEALTHCARE, INC. financial data

Symbol
MOH on NYSE
Location
Long Beach, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 166% % 7%
Debt-to-equity 272% % 16%
Return On Assets 3% % -61%
Operating Margin 1.7% % -59%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51,500,000 shares -7.2%
Common Stock, Shares, Outstanding 51,000,000 shares -8.9%
Entity Public Float $16,000,000,000 USD -7%
Weighted Average Number of Shares Outstanding, Basic 52,800,000 shares -8%
Weighted Average Number of Shares Outstanding, Diluted 52,900,000 shares -8.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $45,426,000,000 USD 12%
General and Administrative Expense $3,009,000,000 USD 9.7%
Costs and Expenses $44,645,000,000 USD 15%
Operating Income (Loss) $781,000,000 USD -54%
Nonoperating Income (Expense) $109,000,000 USD 0.91%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $589,000,000 USD -63%
Income Tax Expense (Benefit) $117,000,000 USD -71%
Net Income (Loss) Attributable to Parent $472,000,000 USD -60%
Earnings Per Share, Basic 8.93 USD/shares -56%
Earnings Per Share, Diluted 8.92 USD/shares -56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,248,000,000 USD -8.9%
Marketable Securities, Current $4,008,000,000 USD -7.3%
Assets, Current $12,444,000,000 USD -2.6%
Deferred Income Tax Assets, Net $178,000,000 USD -14%
Operating Lease, Right-of-Use Asset $30,000,000 USD -14%
Goodwill $1,958,000,000 USD 17%
Other Assets, Noncurrent $147,000,000 USD 6.5%
Assets $15,564,000,000 USD -0.42%
Contract with Customer, Liability, Current $66,000,000 USD 29%
Liabilities, Current $7,372,000,000 USD -6.6%
Operating Lease, Liability, Noncurrent $56,000,000 USD -18%
Other Liabilities, Noncurrent $173,000,000 USD 44%
Liabilities $11,495,000,000 USD 3.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $15,000,000 USD
Retained Earnings (Accumulated Deficit) $3,602,000,000 USD -12%
Stockholders' Equity Attributable to Parent $4,069,000,000 USD -9.5%
Liabilities and Equity $15,564,000,000 USD -0.42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $190,000,000 USD -11%
Net Cash Provided by (Used in) Financing Activities $147,000,000 USD
Net Cash Provided by (Used in) Investing Activities $123,000,000 USD 75%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $214,000,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,348,000,000 USD -8.3%
Deferred Tax Assets, Valuation Allowance $19,000,000 USD 0%
Operating Lease, Liability $71,000,000 USD -14%
Payments to Acquire Property, Plant, and Equipment $22,000,000 USD -19%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $544,000,000 USD -55%
Lessee, Operating Lease, Liability, to be Paid $88,000,000 USD -14%
Property, Plant and Equipment, Gross $1,115,000,000 USD 8.4%
Operating Lease, Liability, Current $15,000,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,000,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year One $18,000,000 USD -5.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.052 pure 4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $17,000,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,000,000 USD -27%
Deferred Tax Assets, Operating Loss Carryforwards $9,000,000 USD 80%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four $7,000,000 USD -22%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $48,000,000 USD 6.7%
Deferred Tax Assets, Net of Valuation Allowance $224,000,000 USD -14%
Interest Expense $108,000,000 USD -1.8%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%